Caina Technology Croissance future
Future contrôle des critères 1/6
Caina Technology is forecast to grow earnings and revenue by 12.3% and 5.5% per annum respectively. EPS is expected to grow by 12.8% per annum. Return on equity is forecast to be 4.9% in 3 years.
Informations clés
12.3%
Taux de croissance des bénéfices
12.8%
Taux de croissance du BPA
| Medical Equipment croissance des bénéfices | 27.5% |
| Taux de croissance des recettes | 5.5% |
| Rendement futur des capitaux propres | 4.9% |
| Couverture par les analystes | Low |
| Dernière mise à jour | 06 Sep 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
This Broker Just Slashed Their Caina Technology Co., Ltd. (SZSE:301122) Earnings Forecasts
Aug 30
The Returns On Capital At Caina Technology (SZSE:301122) Don't Inspire Confidence
Aug 23Caina Technology's (SZSE:301122) Problems Go Beyond Weak Profit
May 01The Returns On Capital At Caina Technology (SZSE:301122) Don't Inspire Confidence
Mar 12Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | 440 | 96 | N/A | 117 | 1 |
| 12/31/2025 | 400 | 81 | N/A | 84 | 1 |
| 12/31/2024 | 361 | 69 | N/A | 99 | 1 |
| 9/30/2024 | 409 | 77 | -48 | 79 | N/A |
| 6/30/2023 | 368 | 114 | -98 | 87 | N/A |
| 3/31/2023 | 391 | 138 | -5 | 178 | N/A |
| 12/31/2022 | 465 | 162 | -26 | 139 | N/A |
| 9/30/2022 | 511 | 174 | 42 | 170 | N/A |
| 6/30/2022 | 516 | 169 | 70 | 186 | N/A |
| 3/31/2022 | 482 | 133 | 20 | 130 | N/A |
| 1/1/2022 | 442 | 131 | 63 | 160 | N/A |
| 9/30/2021 | 409 | 107 | 27 | 117 | N/A |
| 6/30/2021 | 401 | 94 | 33 | 125 | N/A |
| 3/31/2021 | 455 | 122 | 54 | 139 | N/A |
| 12/31/2020 | 505 | 137 | 98 | 170 | N/A |
| 12/31/2019 | 181 | 32 | 9 | 58 | N/A |
| 12/31/2018 | 143 | 20 | 2 | 21 | N/A |
| 12/31/2017 | 93 | 13 | N/A | 0 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 301122's forecast earnings growth (12.3% per year) is above the savings rate (2.9%).
Bénéfices vs marché: 301122's earnings (12.3% per year) are forecast to grow slower than the CN market (25.8% per year).
Croissance élevée des bénéfices: 301122's earnings are forecast to grow, but not significantly.
Chiffre d'affaires vs marché: 301122's revenue (5.5% per year) is forecast to grow slower than the CN market (14% per year).
Croissance élevée des revenus: 301122's revenue (5.5% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: 301122's Return on Equity is forecast to be low in 3 years time (4.9%).